<DOC>
	<DOCNO>NCT01374191</DOCNO>
	<brief_summary>The purpose study determine botulinum toxin type A ( Btx-A ) effective treatment painful neuromas . The ideal therapy painful neuromas would effective , non-addictive , safe , localized , cost-effective treatment . At time , therapy would also address complex peripheral central mechanism . Btx-A potential treatment address requirement preserve exist sensation function . Study Hypothesis : Btx-A injection relief neuroma pain well placebo</brief_summary>
	<brief_title>Botulinum Toxin Type A Neuroma Pain</brief_title>
	<detailed_description>PROJECT SUMMARY OVERVIEW : The purpose study determine botulinum toxin type A ( Btx-A ) effective treatment painful neuromas . The ideal therapy painful neuromas would effective , non-addictive , safe , localized , cost-effective , would also address complex peripheral central mechanism . Btx-A potential treatment address requirement preserve exist sensation function . The investigator believe Btx-A effective eliminating exaggerate local pain response centralization maintain exceptional safety profile potential long-term effect without addictive property . STUDY AIMS : The aim proposal 1 ) examine short-term efficacy Btx-A injection compare placebo treat pain due nerve damage , 2 ) describe long-term efficacy Btx-A injection treat pain due nerve damage measure patient satisfaction quality life change time . APPROACH : Forty patient enrol ; twenty receive active treatment ( Btx-A ) twenty receive placebo ( saline ) . Comparisons treatment placebo occur first 28 day determine Btx-A 's short-term efficacy . Telephone follow-up visit occur Day 2 Week 1 . On Day 28 , telephone follow-up visit occur , except patient experience complication . Patients complication recurrent pain return clinic visit . Post-assessment Day 28 mark begin longitudinal observational study patient outcome . Placebo longer use patient still suffer pain eligible additional Btx-A injection . Patients may receive 4 injection Btx-A 1-year study period pain recurs . During study period participant follow collect data pain-free interval , subsequent treatment choice , patient satisfaction , change quality life function . Group comparison make analyze result . Further stratification data analysis make enrollment number allow control additional demographic disease variable . Quality-adjusted life-years calculate help determine societal individual cost treatment . HYPOTHESIS : The investigator hypothesize 1 ) Btx-A injection relieve neuroma pain good placebo within 28 day injection , 2 ) Btx-A injection relieve neuroma pain longer 28 day , improve patient quality life . Through study investigator intend elucidate efficacy inject Btx-A relieve chronic pain nerve damage characterize patient treatment effective .</detailed_description>
	<mesh_term>Neuroma</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Male female age 1875 year diagnose neuroma pain able return/be available followup evaluation willingness ability give inform consent positive HIV/AIDS otherwise immunocompromised history neuromuscular disease report allergy BOTOXÂ® history symptom significant medical problem last year ( i.e. , bradycardia , impair cardiovascular function , liver disease ) symptoms infection illness initial enrollment pregnant lactate woman unable unwilling maintain abstinence use contraception 28 day follow injection cognitively impaired patient unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>botox</keyword>
	<keyword>neuroma pain</keyword>
	<keyword>pain</keyword>
	<keyword>chronic pain</keyword>
	<keyword>botulinum toxin</keyword>
	<keyword>botulinum toxin A</keyword>
	<keyword>botox pain</keyword>
	<keyword>botox neuroma</keyword>
	<keyword>botox treatment</keyword>
	<keyword>onabotulinum</keyword>
	<keyword>onabotulinum toxin</keyword>
	<keyword>onabotulinum toxin type A</keyword>
</DOC>